Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment

Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment

BackgroundElderly breast cancer (BC) patients have been underrepresented in clinical trials whereas ~60% of deaths from BC occur in women aged 70 years and older. Only limited data are available on the prognostic impact of age according to treatment, especially in the triple-negative (TN) and Her2-p...

Full description

Bibliographic Details
Main Authors: Gilles Houvenaeghel, Monique Cohen, Anthony Gonçalves, Axel Berthelot, Marie Pierre Chauvet, Christelle Faure, Jean Marc Classe, Eva Jouve, Laura Sabiani, Marie Bannier, Louis Tassy, Marc Martino, Agnès Tallet, Alexandre de Nonneville
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
breast cancer
triple negative
HER2-positive
elderly patients
geriatric oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1287253/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1287253/full

Similar Items